Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.

PTEN deletion in luminal cells of mature prostate induces replication stress and senescence in vivo

Open access
Parisotto, Maxime, Grelet, Elise, El Bizri, Rana, Dai, Yongyuan, Terzic, Julie, Eckert, Doriane, Gargowitsch, Laetitia, Bornert, Jean-Marc, Metzger, Daniel · 2018 · Journal of Experimental Medicine

Abstract

Genetic ablation of the tumor suppressor PTEN in prostatic epithelial cells (PECs) induces cell senescence. However, unlike oncogene-induced senescence, no hyperproliferation phase and no signs of DNA damage response (DDR) were observed in PTEN-deficient PECs; PTEN loss-induced senescence (PICS) was reported to be a novel type of cellular senescence. Our study reveals that PTEN ablation in prostatic luminal epithelial cells of adult mice stimulates PEC proliferation, followed by a progressive growth arrest with characteristics of cell senescence. Importantly, we also show that proliferating PTEN-deficient PECs undergo replication stress and mount a DDR leading to p53 stabilization, which is however delayed by Mdm2-mediated p53 down-regulation. Thus, even though PTEN-deficiency induces cellular senescence that restrains tumor progression, as it involves replication stress, strategies promoting PTEN loss–induced senescence are at risk for cancer prevention and therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20171207

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Figures

Graphical abstract
Graphical abstract CC BY-NC-SA · PubMed Central
Figure 1. Characterization of prostate tumors in PTEN(i)pe−/− mice. (A) Prostate weight (normalized over body weight) in PTEN(i)pe−/− and control mice over 12 mo after PTEN ablation. Values are mean of four to six mice ± SEM. (B) Proliferation index (percentage of Ki67-positive epithelial cells) of DLP in PTEN(i)pe−/− and control mice over 12 mo after gene ablation. Values are mean of four to eight mice ± SEM. Data are representative of two experiments. (C) Relative transcript levels of Cdkn1a (p21) and Cdkn2a (p16 and p19ARF) in the prostate of PTEN(i)pe−/− and control mice over 12 mo after gene ablation. Values are mean from four to eight mice ± SEM. (D) Quantification of pHP1γ-positive cells in DLP epithelium of PTEN(i)pe−/− and control mice over 12 mo after gene ablation. Values are mean from four to six mice ± SEM. (E) Representative SA-βGal staining (blue) of DLP sections of PTEN(i)pe−/− and control mice sacrificed at indicated time points after gene ablation. Pink, hematoxylin staining. Bars, 250 µm. Four to six mice were analyzed for each time point. ns, not significant, P value ≥ 0.05; *, P value < 0.05; **, P value < 0.01; ***, P value < 0.001; ****, P value < 0.0001.
Figure 1. Characterization of prostate tumors in PTEN(i)pe−/− mice. (A) Prostate weight (normalized over body weight) in PTEN(i)pe−/− and control mice over 12 mo after PTEN ablation. Values are mean of four to six mice ± SEM. (B) Proliferation index (percentage of Ki67-positive epithelial cells) of DLP in PTEN(i)pe−/− and control mice over 12 mo after gene ablation. Values are mean of four to eight mice ± SEM. Data are representative of two experiments. (C) Relative transcript levels of Cdkn1a (p21) and Cdkn2a (p16 and p19ARF) in the prostate of PTEN(i)pe−/− and control mice over 12 mo after gene ablation. Values are mean from four to eight mice ± SEM. (D) Quantification of pHP1γ-positive cells in DLP epithelium of PTEN(i)pe−/− and control mice over 12 mo after gene ablation. Values are mean from four to six mice ± SEM. (E) Representative SA-βGal staining (blue) of DLP sections of PTEN(i)pe−/− and control mice sacrificed at indicated time points after gene ablation. Pink, hematoxylin staining. Bars, 250 µm. Four to six mice were analyzed for each time point. ns, not significant, P value ≥ 0.05; *, P value < 0.05; **, P value < 0.01; ***, P value < 0.001; ****, P value < 0.0001.CC BY-NC-SA · PubMed Central
Figure 2. Characterization of the senescence-associated secretory phenotype in the prostate of PTEN(i)pe−/− mice. (A–D) Relative transcript levels of Il-1α (A), Il-1β (B), M-CSF (C), and TNFα (D) in the prostate of PTEN(i)pe−/− and control mice over 5 mo after gene ablation. Values are mean of four to six mice ± SEM. Data are representative of three experiments. ns, not significant. *, P value < 0.05; **, P value < 0.01; ****, P value < 0.0001.
Figure 2. Characterization of the senescence-associated secretory phenotype in the prostate of PTEN(i)pe−/− mice. (A–D) Relative transcript levels of Il-1α (A), Il-1β (B), M-CSF (C), and TNFα (D) in the prostate of PTEN(i)pe−/− and control mice over 5 mo after gene ablation. Values are mean of four to six mice ± SEM. Data are representative of three experiments. ns, not significant. *, P value < 0.05; **, P value < 0.01; ****, P value < 0.0001.CC BY-NC-SA · PubMed Central
Figure 3. Characterization of replication stress in PTEN-deficient PECs. (A) Representative γH2AX immunofluorescence staining (red) of DLP sections of PTEN(i)pe−/− and control mice sacrificed 1 mo after gene ablation. Yellow arrow, example of γH2AX-high staining; white arrow, example of γH2AX-low staining. (B) Representative immunofluorescence staining of γH2AX (green) and PCNA (red) of a DLP section of a PTEN(i)pe−/− and of a control mouse sacrificed 1 mo after gene ablation. (C) Representative immunofluorescence staining of γH2AX (red) and BrdU (green) of a DLP section of a PTEN(i)pe−/− mouse sacrificed 1 mo after gene ablation. Blue, Dapi. Bars: main images, 10 µm; insets, 5 µm. Four PTEN(i)pe−/− mice and four control mice were analyzed.
Figure 3. Characterization of replication stress in PTEN-deficient PECs. (A) Representative γH2AX immunofluorescence staining (red) of DLP sections of PTEN(i)pe−/− and control mice sacrificed 1 mo after gene ablation. Yellow arrow, example of γH2AX-high staining; white arrow, example of γH2AX-low staining. (B) Representative immunofluorescence staining of γH2AX (green) and PCNA (red) of a DLP section of a PTEN(i)pe−/− and of a control mouse sacrificed 1 mo after gene ablation. (C) Representative immunofluorescence staining of γH2AX (red) and BrdU (green) of a DLP section of a PTEN(i)pe−/− mouse sacrificed 1 mo after gene ablation. Blue, Dapi. Bars: main images, 10 µm; insets, 5 µm. Four PTEN(i)pe−/− mice and four control mice were analyzed.CC BY-NC-SA · PubMed Central
Figure 4. Immunodetection of DDR markers in PTEN-deficient PECs. (A) Representative immunofluorescence staining of RPA32 (red) of DLP sections of PTEN(i)pe−/− or control mice sacrificed 2 mo after gene ablation. (B) Representative RPA32 pS4/S8 immunofluorescence staining (red) of DLP sections of PTEN(i)pe−/− and control mice sacrificed 1 mo after gene ablation. (C) Representative ATR immunofluorescence staining (red) of DLP sections of PTEN(i)pe−/− and control mice sacrificed 2 mo after gene ablation. (D) Representative immunofluorescence staining of 53BP1 (red) of DLP sections of PTEN(i)pe−/− or control mice sacrificed 2 mo after gene ablation. Blue, Dapi. Bars: main images, 20 µm; insets, 5 µm. Four PTEN(i)pe−/− mice and four control mice were analyzed. A quantification of immunolabeled epithelial cells is shown in each panel. *, P value < 0.05; **, P value < 0.01; ***, P value < 0.001.
Figure 4. Immunodetection of DDR markers in PTEN-deficient PECs. (A) Representative immunofluorescence staining of RPA32 (red) of DLP sections of PTEN(i)pe−/− or control mice sacrificed 2 mo after gene ablation. (B) Representative RPA32 pS4/S8 immunofluorescence staining (red) of DLP sections of PTEN(i)pe−/− and control mice sacrificed 1 mo after gene ablation. (C) Representative ATR immunofluorescence staining (red) of DLP sections of PTEN(i)pe−/− and control mice sacrificed 2 mo after gene ablation. (D) Representative immunofluorescence staining of 53BP1 (red) of DLP sections of PTEN(i)pe−/− or control mice sacrificed 2 mo after gene ablation. Blue, Dapi. Bars: main images, 20 µm; insets, 5 µm. Four PTEN(i)pe−/− mice and four control mice were analyzed. A quantification of immunolabeled epithelial cells is shown in each panel. *, P value < 0.05; **, P value < 0.01; ***, P value < 0.001.CC BY-NC-SA · PubMed Central
Figure 5. Characterization of p53-positive PTEN-deficient PECs. (A) Representative p53 immunofluorescence staining (red) of DLP sections of PTEN(i)pe−/− and control mice sacrificed at indicated time points after gene ablation. White arrow, example of a stained nucleus at 1 mo. (B) Representative BrdU (red) and p53 (green) immunofluorescence staining of DLP sections of PTEN(i)pe−/− and control mice sacrificed 1 mo after gene ablation. White arrow, example of a double-stained nucleus. (C) Representative p53 pS15 (green) and Ki67 (red) immunofluorescence staining of DLP sections of PTEN(i)pe−/− and control mice sacrificed 1 mo after gene ablation. White arrow, example of a double-stained nucleus. Blue, Dapi. Bars: 25 µm (A); 10 µm (B and C). Four PTEN(i)pe−/− mice and four control mice were analyzed.
Figure 5. Characterization of p53-positive PTEN-deficient PECs. (A) Representative p53 immunofluorescence staining (red) of DLP sections of PTEN(i)pe−/− and control mice sacrificed at indicated time points after gene ablation. White arrow, example of a stained nucleus at 1 mo. (B) Representative BrdU (red) and p53 (green) immunofluorescence staining of DLP sections of PTEN(i)pe−/− and control mice sacrificed 1 mo after gene ablation. White arrow, example of a double-stained nucleus. (C) Representative p53 pS15 (green) and Ki67 (red) immunofluorescence staining of DLP sections of PTEN(i)pe−/− and control mice sacrificed 1 mo after gene ablation. White arrow, example of a double-stained nucleus. Blue, Dapi. Bars: 25 µm (A); 10 µm (B and C). Four PTEN(i)pe−/− mice and four control mice were analyzed.CC BY-NC-SA · PubMed Central
Figure 6. Prostate tumor evolution in PTEN/p53(i)pe−/− mice. (A) Evolution of normalized prostate weight (prostate weight over body weight) in PTEN(i)pe−/− and PTEN/p53(i)pe−/− mice over 6 mo after gene ablation. Values are mean from of four to eight mice ± SEM. (B) Proliferation index (percentage of Ki67-positive cells) of DLP epithelial cells in PTEN(i)pe−/− and PTEN/p53(i)pe−/− mice over 6 mo after gene ablation. Values are mean from of four to eight mice ± SEM. (C) Representative views of DLP sections of PTEN/p53(i)pe−/− and control mice sacrificed at 1, 2, and 5 mo after gene ablation and of DLP sections of PTEN/p53(i)pe−/− mice with large tumors, sacrificed 6 mo after gene ablation. Sections were stained with H&E. Bars, 125 µm. Four to eight PTEN/p53(i)pe−/− mice per time point and eight control mice were analyzed. ns, not significant, P value ≥ 0.05; *, P value < 0.05; **, P value < 0.01; ***, P value < 0.001; ****, P value < 0.0001.
Figure 6. Prostate tumor evolution in PTEN/p53(i)pe−/− mice. (A) Evolution of normalized prostate weight (prostate weight over body weight) in PTEN(i)pe−/− and PTEN/p53(i)pe−/− mice over 6 mo after gene ablation. Values are mean from of four to eight mice ± SEM. (B) Proliferation index (percentage of Ki67-positive cells) of DLP epithelial cells in PTEN(i)pe−/− and PTEN/p53(i)pe−/− mice over 6 mo after gene ablation. Values are mean from of four to eight mice ± SEM. (C) Representative views of DLP sections of PTEN/p53(i)pe−/− and control mice sacrificed at 1, 2, and 5 mo after gene ablation and of DLP sections of PTEN/p53(i)pe−/− mice with large tumors, sacrificed 6 mo after gene ablation. Sections were stained with H&E. Bars, 125 µm. Four to eight PTEN/p53(i)pe−/− mice per time point and eight control mice were analyzed. ns, not significant, P value ≥ 0.05; *, P value < 0.05; **, P value < 0.01; ***, P value < 0.001; ****, P value < 0.0001.CC BY-NC-SA · PubMed Central
Figure 7. Characterization of GR1-positive myeloid cells and IL1rn expression during PIN evolution in PTEN(i)pe−/− mice. (A) FACS quantification of GR1-positive myeloid (CD11b-positive) cells in the prostate of PTEN(i)pe−/− and control mice (percentage of the total cells in dissociated prostates) sacrificed at the indicated time points after gene ablation. (B–E) Values are mean of three to six mice ± SEM. Relative transcript levels of CD11b (B), Ly6g (C), Ly6c (D) and IL-1rn (E) in the prostate of PTEN(i)pe−/− and control mice sacrificed at indicated time points after gene ablation. Values are mean of four to ten mice ± SEM. ns, not significant, P value ≥ 0.05; **, P value < 0.01; ****, P value < 0.0001.
Figure 7. Characterization of GR1-positive myeloid cells and IL1rn expression during PIN evolution in PTEN(i)pe−/− mice. (A) FACS quantification of GR1-positive myeloid (CD11b-positive) cells in the prostate of PTEN(i)pe−/− and control mice (percentage of the total cells in dissociated prostates) sacrificed at the indicated time points after gene ablation. (B–E) Values are mean of three to six mice ± SEM. Relative transcript levels of CD11b (B), Ly6g (C), Ly6c (D) and IL-1rn (E) in the prostate of PTEN(i)pe−/− and control mice sacrificed at indicated time points after gene ablation. Values are mean of four to ten mice ± SEM. ns, not significant, P value ≥ 0.05; **, P value < 0.01; ****, P value < 0.0001.CC BY-NC-SA · PubMed Central
Figure 8. Characterization of Mdm2 expression in the prostate of PTEN(i)pe−/− mice. (A) Representative pAKT S473 (green) and Mdm2 (red) immunofluorescence staining of DLP sections of a PTEN(i)pe−/− mouse sacrificed 1 mo after gene ablation. Blue, Dapi. Four mice were analyzed. (B) Representative p53 (green) and Mdm2 immunofluorescence staining (red) of DLP sections of a PTEN(i)pe−/− mouse sacrificed 1 mo after gene ablation. Four mice were analyzed. (C) Representative p53 immunofluorescence staining (red) of DLP sections of PTEN(i)pe−/− mice treated with vehicle- and Nutlin-3 1 mo after gene ablation (n = 3 for each condition). Blue, Dapi. Bars: 20 µm (A and C); 10 µm (B). Data are representative of two experiments; n = 3 vehicle and n = 3 Nutlin-treated PTEN(i)pe−/− mice. (D) Quantification of p53 positive epithelial cells in PINs of PTEN(i)pe−/− mice treated 1 mo after gene ablation with vehicle and Nutlin-3. Data are cumulative of two experiments; n = 3 for each group. Unpaired-t test. ***, P value < 0.001. (E) Relative transcript levels of p21 in the DLP and AP of vehicle- and Nutlin-3 treated PTEN(i)pe−/− mice. n = 7 vehicle and n = 8 Nutlin-3 treated PTEN(i)pe−/− mice. Unpaired-t test. **, P value <0.01.
Figure 8. Characterization of Mdm2 expression in the prostate of PTEN(i)pe−/− mice. (A) Representative pAKT S473 (green) and Mdm2 (red) immunofluorescence staining of DLP sections of a PTEN(i)pe−/− mouse sacrificed 1 mo after gene ablation. Blue, Dapi. Four mice were analyzed. (B) Representative p53 (green) and Mdm2 immunofluorescence staining (red) of DLP sections of a PTEN(i)pe−/− mouse sacrificed 1 mo after gene ablation. Four mice were analyzed. (C) Representative p53 immunofluorescence staining (red) of DLP sections of PTEN(i)pe−/− mice treated with vehicle- and Nutlin-3 1 mo after gene ablation (n = 3 for each condition). Blue, Dapi. Bars: 20 µm (A and C); 10 µm (B). Data are representative of two experiments; n = 3 vehicle and n = 3 Nutlin-treated PTEN(i)pe−/− mice. (D) Quantification of p53 positive epithelial cells in PINs of PTEN(i)pe−/− mice treated 1 mo after gene ablation with vehicle and Nutlin-3. Data are cumulative of two experiments; n = 3 for each group. Unpaired-t test. ***, P value < 0.001. (E) Relative transcript levels of p21 in the DLP and AP of vehicle- and Nutlin-3 treated PTEN(i)pe−/− mice. n = 7 vehicle and n = 8 Nutlin-3 treated PTEN(i)pe−/− mice. Unpaired-t test. **, P value <0.01.CC BY-NC-SA · PubMed Central
Figure 9. Immunodetection of Mdm2 pS163 and quantification of CKIε and p21 transcript levels in DLP of PTEN(i)pe-/- mice. (A) Representative Mdm2 pS163 (red) immunofluorescence staining of DLP sections of control and PTEN(i)pe−/− mice sacrificed at the indicated time after gene ablation. Blue, Dapi. Bars: main images, 40 µm; insets, 10 µm. Data are representative of three experiments with n = 3 mice per time point and two prostate sections per mouse. (B) Transcript levels of CKIε in the DLP and AP of PTEN(i)pe−/− and control mice at the indicated time points. n = 3 for control mice at 5 mo and n = 4, n = 4, n = 4, n = 3, and n = 8 for PTEN(i)pe−/− mice at 1, 2, 3, and 5 mo after gene ablation, respectively. Bars represent the mean ± SEM. One way ANOVA. ns; not significant; **, P < 0.01; ***, P < 0.001. (C) Correlation between p21 and CKI1ε transcript levels in the prostate of PTEN(i)pe−/− mice 5 mo after PTEN ablation.
Figure 9. Immunodetection of Mdm2 pS163 and quantification of CKIε and p21 transcript levels in DLP of PTEN(i)pe-/- mice. (A) Representative Mdm2 pS163 (red) immunofluorescence staining of DLP sections of control and PTEN(i)pe−/− mice sacrificed at the indicated time after gene ablation. Blue, Dapi. Bars: main images, 40 µm; insets, 10 µm. Data are representative of three experiments with n = 3 mice per time point and two prostate sections per mouse. (B) Transcript levels of CKIε in the DLP and AP of PTEN(i)pe−/− and control mice at the indicated time points. n = 3 for control mice at 5 mo and n = 4, n = 4, n = 4, n = 3, and n = 8 for PTEN(i)pe−/− mice at 1, 2, 3, and 5 mo after gene ablation, respectively. Bars represent the mean ± SEM. One way ANOVA. ns; not significant; **, P < 0.01; ***, P < 0.001. (C) Correlation between p21 and CKI1ε transcript levels in the prostate of PTEN(i)pe−/− mice 5 mo after PTEN ablation.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Cited by

See all 51

Metadata

Authors
Parisotto, M., Grelet, E., El Bizri, R., Dai, Y., Terzic, J., Eckert, D., Gargowitsch, L., Bornert, J.-M., & Metzger, D.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Centre National de la Recherche Scientifique UMR7104/Institut National de la Santé et de la Recherche Médicale U1258, Université de Strasbourg, Illkirch Cedex, France
Corresponding author
Metzger, Daniel
Venue
Journal of Experimental Medicine
Published
2018-05-09
Volume
215
Issue
6
Pages
1749-1763
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2802198289
Cited by
43
References
67
Citations by year
2026: 5 · 2025: 5 · 2024: 7 · 2023: 4 · 2022: 7 · 2021: 6 · 2020: 3 · 2019: 2 · 2018: 4
FWCI
2.58
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
  • Centre National de la Recherche Scientifique
  • Institut National de la Santé et de la Recherche Médicale
  • Université de Strasbourg
  • Fondation ARC pour la Recherche sur le Cancer
  • Ligue Contre le Cancer
  • Alsace Contre le Cancer
  • Association pour la Recherche sur les Tumeurs de la Prostate
  • Centre d’Ingénierie Moléculaire Européen
  • Agence Nationale de la Recherche (ANR-10-LABX-0030-INRT)
  • Investissements d’Avenir (ANR-10-IDEX-0002-02)
  • Association pour la Recherche à l’IGBMC
  • Ministère de l’enseignement supérieur et de la recherché
  • Al Bizri Foundation
  • China Scholarship Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
PTEN, replication stress, DNA damage response, p53 stabilization, MDM2, cell proliferation, growth arrest, tumor suppressor, prostate cancer prevention
MeSH terms
Animals, DNA Damage, DNA Repair, Epithelial Cells, Male, Phenotype, Prostate, Prostatic Neoplasms, RNA, Messenger, Stress, Physiological, Biomarkers, Tumor, Signal Transduction, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, Cellular Senescence, Gene Deletion, Myeloid Cells, Cell Proliferation, Proto-Oncogene Proteins c-akt, PTEN Phosphohydrolase, Mice, Proto-Oncogene Proteins c-mdm2, Protein Stability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PTEN deletion in luminal cells of mature prostate induces replication stress and senescence in vivo. https://app.cochat.ai/papers/10.1084/jem.20171207
The paper
Parisotto, M., Grelet, E., El Bizri, R., Dai, Y., Terzic, J., Eckert, D., Gargowitsch, L., Bornert, J.-M., & Metzger, D. (2018). PTEN deletion in luminal cells of mature prostate induces replication stress and senescence in vivo. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20171207

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.